Gabon vs Syrian Arab Republic: Treatment success rate for patients treated for MDR-TB
Gabon
54.0%
in 2022
Syrian Arab Republic
50.0%
in 2022
Gabon rank
136th
Syrian Arab Republic rank
139th
Treatment success rate for patients treated for MDR-TB over time
- Gabon
- Syrian Arab Republic
How they compare
Gabon currently reports 54.0% against 50.0% in Syrian Arab Republic, a difference of 4.0%.
That makes Gabon's figure about 1.1 times Syrian Arab Republic's.
The two have swapped places 3 times across 8 shared years of data; in 2015 it was Syrian Arab Republic ahead.
Gabon ranks 136th and Syrian Arab Republic ranks 139th of 163 countries.
Syrian Arab Republic has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Gabon | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 49.6% | 65.8% | 16.2% | Syrian Arab Republic |
| 2020s | 52.7% | 62.7% | 10.0% | Syrian Arab Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Gabon or Syrian Arab Republic?
- Gabon, at 54.0% against 50.0% in Syrian Arab Republic as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Gabon and Syrian Arab Republic?
- 4.0%, with Gabon ahead.
- How many years of comparable data are there for Gabon and Syrian Arab Republic?
- 8 years are reported by both, from 2015 to 2022.
- How do Gabon and Syrian Arab Republic rank globally for treatment success rate for patients treated for mdr-tb?
- Gabon ranks 136th and Syrian Arab Republic ranks 139th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.